Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Biosimilar-Equivalence'

Biosimilar-Equivalence published presentations and documents on DocSlides.

Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives
Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives
by alida-meadow
Richard Montes, Ph.D.. Hospira. , a Pfizer compan...
Synergy Satellite Event - Biosimilars in colorectal cancer
Synergy Satellite Event - Biosimilars in colorectal cancer
by mia
– what's your gut feeling?. 25th Anniversary EAH...
Building a Biosimilars Pathway in the U.S.
Building a Biosimilars Pathway in the U.S.
by attentionallianz
Richard . Dolinar. , MD. Endocrinologist, Chairman...
The generic and biosimilar
The generic and biosimilar
by alida-meadow
perspective. Warwick Smith. Director General BGMA...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
by aaron
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS
Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS
by myesha-ticknor
Dr Chris Deighton. Consultant Rheumatologist . Co...
U.S. Biosimilars: An Introduction
U.S. Biosimilars: An Introduction
by calandra-battersby
Disclaimers. :. By 2016, 7 of the top 10 pharmace...
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
by myesha-ticknor
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Biosimilar Biological Products
Biosimilar Biological Products
by luanne-stotts
2016 . Clinical Investigator . Training Course. S...
PhAMA Position on Biosimilar Medicines
PhAMA Position on Biosimilar Medicines
by celsa-spraggs
Ms. Leah Goodman. Contents. Key Messages. An Over...
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
by danika-pritchard
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
MODULE 8. Follow-on drugs: generic, biosimilar
MODULE 8. Follow-on drugs: generic, biosimilar
by alida-meadow
& non-biological similar medicinal products ....
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by stefany-barnette
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
ASBM Biosimilars
ASBM Biosimilars
by phoebe-click
US Prescribers and Biosimilars Naming. Kevin Olso...
Latin American Biologics/Biosimilars Conference
Latin American Biologics/Biosimilars Conference
by giovanna-bartolotta
Presented by . the Alliance for Safe Bioloigic . ...
JMP for Biosimilars : Tools for Analytical Similarity
JMP for Biosimilars : Tools for Analytical Similarity
by erica
Sept 16, 2015. W. Heath Rushing, . Adsurgo. LLC. ...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMICS Group Biosimilars 2015 Birmingham, UK. 10-1...
Regulatory aspects and review
Regulatory aspects and review
by mary
of EMA authorized . biosimilars. Session “Biosim...
Challenges in Assessing Therapeutic Equivalence of
Challenges in Assessing Therapeutic Equivalence of
by thomas
Nanosimilars. Beat . Flühmann. Global Lead NBCD ....
Non-inferiority And Equivalence
Non-inferiority And Equivalence
by delilah
Design considerations and sample size. Demonstrate...
Table 2 WASISubtest Input and Output Requirements and Equivalence Evid
Table 2 WASISubtest Input and Output Requirements and Equivalence Evid
by cora
SubtestInputaOutputbDirect evidencecEvidence for s...
Cost equivalence A/Prof Dominic Wilkinson
Cost equivalence A/Prof Dominic Wilkinson
by verticalbikers
25/2/2016. Director of Medical Ethics. Oxford Uehi...
An Equivalence Class for Orthogonal Vectors
An Equivalence Class for Orthogonal Vectors
by pasty-toler
Lijie. Chen. MIT. Ryan Williams. MIT. Fine-Grain...
Formal and Dynamic Equivalence and the principle of equivalent
Formal and Dynamic Equivalence and the principle of equivalent
by sherrill-nordquist
effect. Based on . Eugene . Nida’s Theory. Intr...
Economic Equivalence
Economic Equivalence
by test
Lecture No. . 5. Chapter 3. Contemporary Engineer...
In and out of equivalence
In and out of equivalence
by faustina-dinatale
Anthony Pym . Master of Translation . . Your que...
Strategic and practical measures to ensure equivalence in a
Strategic and practical measures to ensure equivalence in a
by natalia-silvester
Professor Philip Bradley. School of Medical Educa...
Equivalence Relations:
Equivalence Relations:
by faustina-dinatale
Selected Exercises. Copyright © Peter Cappello....
The notion of equivalence
The notion of equivalence
by pamella-moone
Historically, equivalence has represented one of ...
Bayesian approach to equivalence study of medical device
Bayesian approach to equivalence study of medical device
by cheryl-pisano
1. 1. http://www.accessdata.fda.gov/cdrh_docs/pdf...
Equivalence Relations:
Equivalence Relations:
by karlyn-bohler
Selected Exercises. Copyright © Peter Cappello....
Equivalence
Equivalence
by faustina-dinatale
The many different definitions of equivalence in ...
Equivalence principle and antigravity
Equivalence principle and antigravity
by liane-varnes
Equivalence Equivalence principle: principle: in...
Category 1: Defining Terms
Category 1: Defining Terms
by jasmine
Clue: . A biologic product with no clinically mean...
  What is the value of Real-World Evidence for Biosimilars?
  What is the value of Real-World Evidence for Biosimilars?
by bitsy
Disclaimer. This panel is moderated by Dr. Delphin...
Budget impact and cost-effectiveness of oncology
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
INSIGHTS INTO THE MARKET
INSIGHTS INTO THE MARKET
by summer
FOR INFLIXIMABTable of ContentsThe Evolving Landsc...
22 MayEMACHMPBWP2477132012Committee for Medicinal Products for Hum
22 MayEMACHMPBWP2477132012Committee for Medicinal Products for Hum
by carla
Adoption by CHMP for release for consultation24 Ma...
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
by iamamercy
Dr.G.Hima. . Bindu. ...